D. Rogers

发表

Novel targets and drugs in inflammatory lung disease.

L. Donnelly, D. Rogers, 2008, Current opinion in pharmacology.

Airway inflammation after controlled exposure to diesel exhaust particulates.

P. Cullinan, K. Chung, R. Kinnersley, 2000, American journal of respiratory and critical care medicine.

Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells

J. Seagrave, D. Rogers, D. Hill, 2012, Respiratory Research.

Tachykinin receptor antagonists for asthma and COPD

D. Rogers, 2001 .

Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease

D. Rogers, S. Culpitt, S. V. Culpitt, 2000, Expert opinion on pharmacotherapy.

Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BKCa channels and inhibition of neurotransmitter release

M. Belvisi, D. Rogers, Yu‐Chih Liu, 1999, British journal of pharmacology.

Pulmonary mucus: Pediatric perspective

D. Rogers, 2003, Pediatric pulmonology.

Airway hypersecretion in allergic rhinitis and asthma: New pharmacotherapy

D. Rogers, 2003, Current allergy and asthma reports.

Determining equivalence of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at Royal Brompton National Heart & Lung Institute, London 24 June 1994.

D. Rogers, D. Ganderton, 1995, Respiratory medicine.

Oral N-acetylcysteine speeds reversal of cigarette smoke-induced mucous cell hyperplasia in the rat.

D. Rogers, P. Jeffery, S. Majumdar, 1988, Experimental lung research.

Development of new treatments for lung disease

D. Rogers, T. Tetley, 1996 .

The airway goblet cell.

D. Rogers, 2003, The international journal of biochemistry & cell biology.

Neurogenic inflammation in the airways: characterisation of electrical parameters for vagus nerve stimulation in the guinea pig

P. Barnes, M. Belvisi, D. Rogers, 1990, Journal of Neuroscience Methods.

Airway Mucus: Basic Mechanisms and Clinical Perspectives

D. Rogers, M. Lethem, 1997, Respiratory Pharmacology and Pharmacotherapy.

New perspectives on basic mechanisms in lung disease

D. Rogers, Duncan F. Rogers, 1992 .

Phytoceuticals: the new ‘physic garden’ for asthma and chronic obstructive pulmonary disease

L. Donnelly, D. Rogers, Sumalatha Grandhi, 2007, Expert review of respiratory medicine.

Plasma exudation. Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo.

P. Boschetto, P. Barnes, D. Rogers, 1989, Journal of pharmacological methods.

Airway mucus hypersecretion in asthma: an undervalued pathology?

D. Rogers, 2004, Current opinion in pharmacology.

Airway Mucus Hypersecretion in Asthma and COPD

D. Rogers, 2009 .

Overview of Airway Mucus Clearance

D. Rogers, 2004 .

New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.

D. Rogers, HonYee Lai, 2010, Journal of aerosol medicine and pulmonary drug delivery.

Airway goblet cell hyperplasia in asthma: hypersecretory and anti‐inflammatory?

D. Rogers, 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Intravenously administered oligonucleotides can be delivered to conducting airway epithelium via the bronchial circulation

D. Rogers, E. Alton, L. Huang, 2006, Gene Therapy.

Airway Submucosal Glands: Physiology and Pharmacology

D. Rogers, D. C. Fung, 1997 .

Influence of Respiratory Tract Fluid on Airway Calibre

D. Rogers, 1994 .

Chapter 28 – Understanding Botulinum Neurotoxin Mechanism of Action and Structure to Enhance Therapeutics and Improve Care

D. Rogers, K. Foster, Emily J. Adams, 2009 .

Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.

P. Barnes, L. Donnelly, D. Rogers, 2005, Respiratory medicine.

Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea‐pig and platelet aggregation in man

T. Evans, P. Barnes, D. Rogers, 1988, British journal of pharmacology.

Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.

K. Chung, T. Evans, P. Barnes, 1987, Journal of applied physiology.

Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin‐sensitized guinea‐pigs in vitro

D. Rogers, Yu‐Chih Liu, Y. Liu, 1998, British journal of pharmacology.

Neurogenic goblet cell secretion and bronchoconstriction in guinea pigs sensitised to trimellitic anhydride.

K. Chung, H. Kuo, P. Barnes, 1995, European journal of pharmacology.

Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig.

K. Chung, T. Evans, P. Barnes, 1989, Clinical science.

Pathophysiology of Airway Mucus Secretion in Asthma

D. Rogers, Yu‐Chih Liu, A. Khawaja, 1998 .

Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea‐pigs in vivo

P. Barnes, D. Rogers, Y. Hirayama, 1993, British journal of pharmacology.

Ovalbumin aerosol challenge in actively sensitized guinea pigs: relationship between airway microvascular leakage and airflow obstruction

K. P. Hui, J. Lötvall, D. Rogers, 1992, Allergy.

Effect of platelet activating factor on formation and composition of airway fluid in the guinea‐pig trachea.

P. Boschetto, P. Barnes, D. Rogers, 1990, The Journal of physiology.

E V ect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects

P. Barnes, J. Nightingale, D. Rogers, 1999 .

ect of inhaled ozone on exhaled nitric oxide , pulmonary function , and induced sputum in normal and asthmatic subjects

P. Barnes, J. Nightingale, D. Rogers, 1999 .

Reflexly runny noses: neurogenic inflammation in the nasal mucosa

D. Rogers, 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease.

P. Barnes, L. Donnelly, D. Rogers, 2002, American journal of respiratory and critical care medicine.

Bradykinin‐induced plasma exudation in guinea‐pig airways: involvement of platelet activating factor

P. Barnes, D. Rogers, S. Dijk, 1990, British journal of pharmacology.

e of increased airway microvascular permeability and plasma exudation in asthma

K. Chung, T. Evans, P. Barnes, 2012 .

Effect of antiasthma drugs on microvascular leakage in guinea pig airways.

P. Boschetto, P. Barnes, D. Rogers, 1989, The American review of respiratory disease.

Motor control of airway goblet cells and glands.

D. Rogers, 2001, Respiration physiology.

Muscarinic control of airway mucus secretion

D. Rogers, 2001 .

Cigarette smoke-induced airway goblet cell secretion: dose-dependent differential nerve activation.

H. Kuo, P. Barnes, D. Rogers, 1992, The American journal of physiology.

Differential inhibitory effects of opioids on cigarette smoke, capsaicin and electrically‐induced goblet cell secretion in guinea‐pig trachea

H. Kuo, P. Barnes, D. Rogers, 1992, British journal of pharmacology.

Capsaicin and sensory neuropeptide stimulation of goblet cell secretion in guinea‐pig trachea.

H. Kuo, P. Barnes, D. Rogers, 1990, The Journal of physiology.

Neural control of goblet cell secretion in guinea pig airways.

H. Kuo, P. Barnes, D. Rogers, 1990, The American journal of physiology.

Inhibition of neurogenic plasma exudation in guinea‐pig airways by CP‐96,345, a new non‐peptide NK1 receptor antagonist

P. Barnes, D. Rogers, Y. Lei, 1992, British journal of pharmacology.

Effects and interactions of opioids on plasma exudation induced by cigarette smoke in guinea pig bronchi.

D. Rogers, Y. Lei, 1999, American journal of physiology. Lung cellular and molecular physiology.

Effects and interactions of opioids on plasma exudation induced by cigarette smoke in guinea pig bronchi.

D. Rogers, Y. Lei, 1999, The American journal of physiology.

Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion.

K. Chung, T. Evans, P. Barnes, 1990, Environmental health perspectives.

Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects

K. Chung, P. Barnes, J. Nightingale, 1998, Thorax.

Neural control of airway mucus secretion.

D. Rogers, A. Dewar, 1990, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Effects of tachykinins on mucus secretion in human bronchi in vitro.

P. Barnes, D. Rogers, B. Aursudkij, 1989, European journal of pharmacology.

Neurogenic inflammation in lung disease: Burnt out?

D. Rogers, 1997, InflammoPharmacology.

Modulation of neurogenic inflammation: novel approaches to inflammatory disease.

P. Barnes, M. Belvisi, D. Rogers, 1990, Trends in pharmacological sciences.

Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.

D. Rogers, 2000, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Adrenaline, But not Salbutamol Inhibits Airway Microvascular Leakage in Guinea Pigs

P. Boschetto, P. Barnes, D. Rogers, 1988 .

No effect of inhaled budesonide on the response to inhaled ozone in normal subjects.

K. Chung, P. Barnes, J. Nightingale, 2000, American journal of respiratory and critical care medicine.

Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma.

P. Barnes, J. Nightingale, D. Rogers, 1999, American journal of respiratory and critical care medicine.

Mechanisms and modulation of airway plasma exudation after direct inhalation of cigarette smoke.

P. Barnes, D. Rogers, Y. Lei, 1995, American journal of respiratory and critical care medicine.

Pharmacological regulation of the neuronal control of airway mucus secretion.

D. Rogers, 2002, Current opinion in pharmacology.

New ideas on the pathophysiology and treatment of lung disease

G. Laurent, D. Rogers, 1998, Thorax.

On muscarinic control of neurogenic mucus secretion in ferret trachea.

J. Mak, D. Rogers, E. Haddad, 1996, The Journal of physiology.

‘Sensory‐efferent’ neural control of mucus secretion: characterization using tachykinin receptor antagonists in ferret trachea in vitro

D. Rogers, Y. Hirayama, Peter J. Barnes, 1994, British journal of pharmacology.

Tachykinin control of ferret airways: Mucus secretion, bronchoconstriction and receptor mapping

J. Mak, D. Rogers, S. Meini, 1993, Neuropeptides.

Impaired stimulus-evoked mucus secretion in cystic fibrosis bronchi.

D. Rogers, E. Alton, A. Dewar, 1993, Experimental lung research.

OPIOID INHIBITION OF NEURALLY MEDIATED MUCUS SECRETION IN HUMAN BRONCHI

D. Rogers, P. Barnes, 1989, The Lancet.

Cigarette smoke-induced 'chronic bronchitis': a study in situ of laryngo-tracheal hypersecretion in the rat.

D. Rogers, P. Jeffery, N. Turner, 1987, Clinical science.

Neurogenic inflammation in the airways: Measurement of microvascular leakage

M. Belvisi, D. Rogers, 1998 .

Cigarette smoke‐inhibition of neurogenic bronchoconstriction in guinea‐pigs in vivo: involvement of exogenous and endogenous nitric oxide

D. Rogers, J. Emms, Joanne C. Emms, 1997, British journal of pharmacology.

Involvement of hydroxyl radicals in neurogenic airway plasma exudation and bronchoconstriction in guinea‐pigs in vivo

P. Barnes, D. Rogers, Y. Lei, 1996, British journal of pharmacology.

Neurogenic plasma extravasation: inhibition by morphine in guinea pig airways in vivo.

P. Barnes, M. Belvisi, D. Rogers, 1989, Journal of applied physiology.

Airway hyperresponsiveness: relation to asthma and inflammation?

B. O'connor, D. Rogers, 1993, Thorax.

Plasma exudation and oedema in asthma.

T. Evans, D. Rogers, 1992, British medical bulletin.

Neuroregulation of mucus secretion by opioid receptors and KATP and BKCa channels in ferret trachea in vitro

D. Rogers, Y. Liu, S. Ramnarine, 1998, British journal of pharmacology.

K+ channel activator inhibition of neurogenic goblet cell secretion in guinea pig trachea.

H. Kuo, P. Barnes, D. Rogers, 1992, European journal of pharmacology.

Effect of vasoactive intestinal peptide (VIP)‐related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro

D. Rogers, Yu‐Chih Liu, Y. Liu, 1999, British journal of pharmacology.

ect of vasoactive intestinal peptide ( VIP )-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro 2

D. Rogers, Yu‐Chih Liu, A. Khawaja, 1999 .

Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea pigs.

K. Chung, T. Evans, P. Barnes, 1988, The American review of respiratory disease.

Asthma therapy for the 21st century.

D. Rogers, M. Giembycz, 1998, Trends in pharmacological sciences.

Effect of repeated sputum induction on cell counts in normal volunteers.

P. Barnes, J. Nightingale, D. Rogers, 1998, Thorax.

Indomethacin and flurbiprofen speed recovery of rat bronchial epithelium after exposure to cigarette smoke.

D. Rogers, P. Jeffery, 1986, Experimental lung research.

The mechanisms and control of bronchial mucous cell hyperplasia.

D. Rogers, P. Jeffery, M. Ayers, 1982, Advances in experimental medicine and biology.

Consensus statement from a workshop of the British Association for Lung Research, held at Royal Brompton National Heart & Lung

D. Rogers, D. Ganderton, 1995 .

The Microanatomy of Airway Mucus Secretion

D. Rogers, T. Newman, 1997 .

Therapeutic Options for Hydrating Airway Mucus in Cystic Fibrosis

D. Rogers, B. Tildy, Bernadett E. Tildy, 2015, Pharmacology.

Nitric oxide inhibition of basal and neurogenic mucus secretion in ferret trachea in vitro

P. Barnes, D. Rogers, A. Khawaja, 1996, British journal of pharmacology.

vin-induced plasma exudation in guinea-pig airways in vivo and the effect of neutrophil depletion

K. Chung, M. Belvisi, D. Rogers, 2012 .

Inhibition of neurogenic plasma exudation and bronchoconstriction by a K+ channel activator, BRL 38227, in guinea pig airways in vivo.

P. Barnes, D. Rogers, Y. Lei, 1993, European journal of pharmacology.

Re-engineering the target specificity of clostridial neurotoxins - a route to novel therapeutics

D. Rogers, C. Cruttwell, C. Shone, 2006, Neurotoxicity Research.

Human Airway Inflammation

L. Donnelly, D. Rogers, 2001 .

Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD

P. Shah, P. Barnes, L. Donnelly, 2003, Thorax.

Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea‐pigs

T. Evans, P. Barnes, M. Belvisi, 1988, British journal of pharmacology.

Mucus hypersecretion in chronic obstructive pulmonary disease.

D. Rogers, 2008, Novartis Foundation symposium.

Regulation of NANC neural bronchoconstriction in vivo in the guinea‐pig: involvement of nitric oxide, vasoactive intestinal peptide and soluble guanylyl cyclase

P. Barnes, D. Rogers, Y. Lei, 1993, British journal of pharmacology.

COPD: new developments and therapeutic opportunities.

P. Barnes, D. Rogers, 1999, Trends in pharmacological sciences.

Effect of non-peptide tachykinin NK(1) receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea.

D. Rogers, Y. Liu, A. Khawaja, 1999, European journal of pharmacology.

Inhibition of cigarette smoke-induced airway secretory cell hyperplasia by indomethacin, dexamethasone, prednisolone, or hydrocortisone in the rat.

D. Rogers, P. Jeffery, 1986, Experimental lung research.

The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?

L. Donnelly, D. Rogers, Catherine Gwilt, 2007, Pharmacology & therapeutics.

Tachykinins: receptor to effector.

D. Rogers, A. Khawaja, Duncan F. Rogers, 1996, The international journal of biochemistry & cell biology.

Proteomic analysis of polymeric salivary mucins: no evidence for MUC19 in human saliva.

D. Rogers, P. Clegg, D. Thornton, 2008, The Biochemical journal.

Airway Mucus Secretion

D. Rogers, 2005 .

The Role of Airway Secretions in COPD: Pathophysiology, Epidemiology and Pharmacotherapeutic Options

D. Rogers, 2005, COPD.

Tracheal potential difference in the reserpine and isoproterenol rat models of cystic fibrosis.

D. Geddes, D. Rogers, E. Alton, 1990, Experimental lung research.

Physiology of airway mucus secretion and pathophysiology of hypersecretion.

D. Rogers, Duncan F Rogers, 2007, Respiratory care.

Airway goblet cells: responsive and adaptable front-line defenders.

D. Rogers, Duncan F. Rogers, 1994, The European respiratory journal.

Therapy for Chronic Obstructive Pulmonary Disease in the 21st Century

L. Donnelly, D. Rogers, 2012, Drugs.

Effect of oral acetylcysteine on tobacco smoke-induced secretory cell hyperplasia.

D. Rogers, P. Jeffery, M. Ayers, 1985, European journal of respiratory diseases. Supplement.

Treatment of airway mucus hypersecretion

P. Barnes, D. Rogers, 2006, Annals of medicine.

Airway mucus hypersecretion: Rationales for pharmacotherapy

D. Rogers, 2006 .

Antiproteases and retinoids for treatment of chronic obstructive pulmonary disease

L. Donnelly, D. Rogers, 2003 .

Mucoactive agents for airway mucus hypersecretory diseases.

D. Rogers, 2007, Respiratory care.

Microanatomy of secretory granule release from guinea pig tracheal goblet cells.

D. Rogers, A. Robichaud, T. Newman, 1996, American journal of respiratory cell and molecular biology.

Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy

D. Rogers, Duncan F Rogers, Hon Yee Lai, 2010, Current opinion in allergy and clinical immunology.

Inhibition by oral N-acetylcysteine of cigarette smoke-induced "bronchitis" in the rat.

D. Rogers, P. Jeffery, 1986, Experimental lung research.

Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases

D. Rogers, Emily Ha, 2015, Pharmacology.

Corticosteroid inhibition of airway microvascular leakage.

L. Fabbri, P. Boschetto, P. Barnes, 1991, The American review of respiratory disease.

CHRONIC EFFRCTS OF DR.UGS ON AIR.WAY MUCU~SECRETING CELLS

D. Rogers, P. Jeffery, M. Ayres, 1984 .

Chronic Effects of Drugs on Airway Mucus-Secreting Cells

D. Rogers, P. Jeffery, D. William, 1984 .

Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.

P. Shah, P. Barnes, L. Donnelly, 2003, American journal of respiratory and critical care medicine.

GABA‐Mediated Synaptic Interaction Between the Visual and Vestibular Pathways of Hermissenda

D. Alkon, L. Matzel, I. Kapetanovic, 1993, Journal of neurochemistry.

Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options.

D. Rogers, 2005, Pulmonary pharmacology & therapeutics.

Mucus hypersecretion in COPD

D. Rogers, 2004 .

Mucoactive drugs for asthma and COPD: any place in therapy?

D. Rogers, 2002, Expert opinion on investigational drugs.

Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects

P. Barnes, J. Nightingale, D. Rogers, 1999, Thorax.

Measurement of airway mucin gene expression.

D. Rogers, K. Pritchard, A. Smith, 2001, Methods in molecular medicine.

Structural Aspects of Cigarette Smoke-Induced Pulmonary Disease

D. Rogers, P. A. Shields, M. Ayers, 1984 .

Effect of fenspiride, a non-steroidal antiinflammatory agent, on neurogenic mucus secretion in ferret trachea in vitro.

D. Rogers, Y. Liu, A. Khawaja, 1999, Pulmonary pharmacology & therapeutics.

Nicotine does not cause 'bronchitis' in the rat.

D. Williams, D. Rogers, P. Jeffery, 1986, Clinical science.

Neurokinin receptors subserving airways secretion.

D. Rogers, 1995, Canadian journal of physiology and pharmacology.

Oral N-acetylcysteine or S-carboxymethylcysteine inhibit cigarette smoke-induced hypersecretion of mucus in rat larynx and trachea in situ.

D. Rogers, P. Jeffery, P. Jeffery, 1989, The European respiratory journal.

Impaired Inhibition by Dexamethasone of Cytokine Release by Alveolar Macrophages from COPD Patients

Pallav L. Shah, Sarah V. Culpitt, Duncan F. Rogers, 2002 .

Scorpion venoms: taking the sting out of lung disease.

D. Rogers, D. F. Rogers, 1996, Thorax.

Bioelectric properties of cystic fibrosis airways obtained at heart-lung transplantation.

M. Yacoub, D. Geddes, D. Rogers, 1992, Thorax.

Human airway inflammation : sampling techniques and analytical protocols

L. Donnelly, D. Rogers, 2001 .

Effect of the long‐acting tachykinin NK1 receptor antagonist MEN 11467 on tracheal mucus secretion in allergic ferrets

D. Rogers, S. Manzini, Yu‐Chih Liu, 2001, British Journal of Pharmacology.

Comparison of the effects of salmeterol and formoterol in patients with severe asthma.

P. Barnes, J. Nightingale, D. Rogers, 2002, Chest.

In vivo preclinical test models for studying airway mucus secretion.

D. Rogers, 1997, Pulmonary Pharmacology & Therapeutics.

Effect of human neutrophil proteases on ex vivo small airway function

L. Donnelly, D. Rogers, Natasha Madge, 2013 .

Airway Mucus Secretion

D. Rogers, 2005 .

Cigarette Smoke Induced Tracheal Hypersecretion

D. Rogers, P. Jeffery, N. Turner, 1985 .

New perspectives on basic mechanisms in lung disease

D. Rogers, 1992 .